The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

ASH 2019 Review: Current Updates in Hematologic Diseases
13:23

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on MDS: Definitions and the Notion of Risk

FEATURING Mikkael Sekeres
  • 6 views
  • February 13, 2020
14:52

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on Low-Risk MDS: Ameliorating Anemia

FEATURING Mikkael Sekeres
  • 8 views
  • February 13, 2020
05:28

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on Low-Risk MDS: Tackling Thrombocytopenia / Modifying Multilineage Dysplasia

FEATURING Mikkael Sekeres
  • 9 views
  • February 13, 2020
09:05

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on the Higher-Risk MDS: HMA & HCT - Need to Focus on Response Duration and Overall Survival, Goals of Therapy Should Reflect Goals of Patient

FEATURING Mikkael Sekeres
  • 48 views
  • February 13, 2020
06:19

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update: Adding Targeted Agents to Intensive Therapy in AML Looks Promising

FEATURING Heather Male
  • 16 views
  • February 13, 2020
09:18

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update: Understanding the Leukemia Mutational Profile in a Timely Fashion Helps "Unfit" & R/R AML Patients

FEATURING Heather Male
  • 108 views
  • February 13, 2020
  • 1
10:05

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update: CC-486 Demonstrated Improvement in OS and RFS in Maintenance Therapy for AML

FEATURING Heather Male
  • 98 views
  • February 13, 2020
36:19

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on Myeloproliferative Neoplasms: CPI-0610 (BET Inhibitor) Mono or + Ruxolitinib Demonstrated Antitumor Activity in R/R/I Disease

FEATURING Ronald Hoffman
  • 15 views
  • February 13, 2020
20:32

KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on the Bone Marrow Procedures with a Dry Tap: KUH Dry Tap Protocol - Emerging Data May Point Towards Using MRD in Treatment Strategies

FEATURING Janet Woodroof
  • 5 views
  • February 13, 2020